IRES-mediated translation of utrophin A is enhanced by glucocorticoid treatment in skeletal muscle cells

PLoS ONE

Volumn 3, Issue 6, 2008, Pages

  Miura, Pedro ^a   Andrews, Meghan ^b   Holcik, Martin ^b   Jasmin, Bernard J ^a,c  

^a UNIVERSITY OF OTTAWA   (Canada)

^b CHILDREN S HOSPITAL OF EASTERN ONTARIO   (Canada)

^c OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOCORTICOID; MESSENGER RNA; METHYLPREDNISOLONE SODIUM SUCCINATE; UTROPHIN; PRIMER DNA; UTRN PROTEIN, MOUSE;

5' UNTRANSLATED REGION; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; DUCHENNE MUSCULAR DYSTROPHY; GENETIC TRANSFECTION; INTERNAL RIBOSOME ENTRY SITE; MOUSE; MUSCLE CELL; MYOTUBE; NONHUMAN; POLYSOME; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN TARGETING; REGULATORY MECHANISM; REPORTER GENE; SKELETAL MUSCLE; TRANSLATION REGULATION; ANIMAL; DRUG EFFECT; GENETICS; METABOLISM; NUCLEOTIDE SEQUENCE; PROTEIN SYNTHESIS; RIBOSOME;

ANIMALS; BASE SEQUENCE; DNA PRIMERS; METHYLPREDNISOLONE HEMISUCCINATE; MICE; MUSCLE, SKELETAL; PROTEIN BIOSYNTHESIS; RIBOSOMES; RNA, MESSENGER; UTROPHIN;

EID: 48649086140     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0002309     Document Type: Article

References (58)

1. Mendell JR, Moxley RT, Griggs RC, Brooke MH, Fenichel GM, et al. (1989) Randomized, double-blind six-month trial of prednisone in Duchenne's muscular dystrophy. N Engl J Med 320: 1592-1597.
2. Biggar WD, Gingras M, Fehlings DL, Harris VA, Steele CA (2001) Deflazacort treatment of Duchenne muscular dystrophy. J Pediatr 138: 45-50.
3. Fenichel GM, Florence JM, Pestronk A, Mendell JR, Moxley RT III, et al. (1991) Long-term benefit from prednisone therapy in Duchenne muscular dystrophy. Neurology 41: 1874-1877.
4. DeSilva S, Drachman DB, Mellits D, Kuncl RW (1987) Prednisone treatment in Duchenne muscular dystrophy. Long-term benefit. Arch Neurol 44: 818-822.
5. Tidball JG, Wehling-Henricks M (2004) Evolving therapeutic strategies for Duchenne muscular dystrophy: targeting downstream events. Pediatr Res 56: 831-841.
6. St Pierre SJ, Chakkalakal JV, Kolodziejczyk SM, Knudson JC, Jasmin BJ, et al. (2004) Glucocorticoid treatment alleviates dystrophic myofiber pathology by activation of the calcincurin/NF-AT pathway. FASEB J 18: 1937-1939.
7. Khurana TS, Davies KE (2003) Pharmacological strategies for muscular dystrophy. Nat Rev Drug Discov 2: 379-390.
8. Miura P, Jasmin BJ (2006) Utrophin upregulation for treating Duchenne or Becker muscular dystrophy: how close are we? Trends Mol Med 12: 122-129.
9. Tinsley JM, Potter AC, Phelps SR, Fisher R, Trickett JI, et al. (1996) Amelioration of the dystrophic phenotype of mdx mice using a truncated utrophin transgene. Nature 384: 349-353.
10. Gilbert R, Nalbantoglu J, Petrof BJ, Ebihara S, Guibinga GH, et al. (1999) Adenovirus-mediated utrophin gene transfer mitigates the dystrophic phenotype of mdx mouse muscles. Hum Gene Ther 10: 1299-1310.
11. Cerletti M, Negri T, Cozzi F, Colpo R, Andreetta F, et al. (2003) Dystrophic phenotype of canine X-linked muscular dystrophy is mitigated by adenovirus- mediated utrophin gene transfer. Gene Ther 10: 750-757.
12. Pasquini F, Guerin C, Blake D, Davies K, Karpati G, et al. (1995) The effect or glucocorticoids on the accumulation or utrophin by cultured normal and dystrophic human skeletal muscle satellite cells. Neuromuscul Disord 5: 105-114.
13. Courdier-Fruh I, Barman L, Briguet A, Meier T (2002) Glucocorticoid-mediated regulation of utrophin levels in human muscle fibers. Neuromuscul Disord 12 Suppl 1: S95-104.
14. Gramolini AO, Karpati G, Jasmin BJ (1999) Discordant expression of utrophin and its transcript in human and mouse skeletal muscles. Journal of Neuropathology and Experimental Neurology 58: 235-244.
15. Weir AP, Burton EA, Harrod G, Davies KE (2002) A- and B-utrophin have different expression patterns and are differentially up-regulated in mdx muscle. J Biol Chem 277: 45285-45290.
16. Miura P, Thompson J, Chakkalakal JV, Holcik M, Jasmin BJ (2005) The Utrophin A 5′-Untranslated Region Confers Internal Ribosome Entry Site-mediated Translational Control during Regeneration of Skeletal Muscle Fibers. J Biol Chem 280: 32997-33005.
17. Holcik M, Sonenberg N (2005) Translational control in stress and apoptosis. Nat Rev Mol Cell Biol 6: 318-327.
18. Courdier-Fruh I, Barman L, Wettstein P, Meier T (2003) Detection of glucocorticoid-like activity in traditional Chinese medicine used for the treatment of Duchenne muscular dystrophy. Neuromuscul Disord 13: 699-704.
19. Galy B, Maret A, Prats AC, Prats H (1999) Cell transformation results in the loss of the density-dependent translational regulation of the expression of fibroblast growth factor 2 isoforms. Cancer Res 59: 165-171.
20. Martineau Y, Le BC, Monbrun L, Allo V, Chiu IM, et al. (2004) Internal ribosome entry site structural motifs conserved among mammalian fibroblast growth factor 1 alternatively spliced mRNAs. Moll Cell Biol 24: 7622-7635.
21. Shah OJ, Kimball SR, Jefferson LS (2000) Among translational effectors, p70S6k is uniquely sensitive to inhibition by glucocorticoids. Biochem J 347: 389-397.
22. Shah OJ, Kimball SR, Jefferson LS (2000) Acute attenuation of translation initiation and protein synthesis by glucocorticoids in skeletal muscle. Am J Physiol Endocrinol Metab 278: E76-E82.
23. Bonet-Kerrache A, Fortier M, Comunale F, Gauthier-Rouviere C (2005) The GTPase RhoA increases utrophin expression and stability, as well as its localization at the plasma membrane. Biochem J 391: 261-268.
24. Shah OJ, Kimball SR, Jefferson LS (2000) Glucocorticoids abate p70(S6k) and eIF4E function in L6 skeletal myoblasts. Am J Physiol Endocrinol Metab 279: E74-EB2.
25. Shah OJ, Anthony JC, Kimball SR, Jefferson LS (2000) Glucocorticoids oppose translational control by leucine in skeletal muscle. Am J Physiol Endocrinol Metab 279: E1185-E1190.
26. Shah OJ, Iniguez-Lluhi JA, Romanelli A, Kimball SR, Jefferson LS (2002) The activated glucocorticoid receptor modulates presumptive autoregulation of ribosomal protein S6 protein kinase, p70 S6K. J Biol Chem 277: 2525-2533.
27. Sarnow P (1989) Translation of glucose-regulated protein 78/ immunoglobulin heavy-chain binding protein mRNA is increased in poliovirus-infected cells at a time when cap-dependent translation of cellular mRNAs is inhibited. Proc Natl Acad Sci U S A 86: 5795-5799.
28. Qin X, Sarnow P (2004) Preferential translation of internal ribosome entry site-containing mRNAs during the mitotic cycle in mammalian cells. J Biol Chem 279: 13721-13728.
29. Warnakulasuriyarachchi D, Cerquozzi S, Cheung HH, Holcik M (2004) Translational induction of the inhibitor of apoptosis protein HIAP2 during endoplasmic reticulum stress attenuates cell death and is mediated via an inducible internal ribosome entry site element. J Biol Chem 279: 17148-17157.
30. Verdi JM, Campagnoni AT (1990) Translational regulation by steroids. Identification of a steroid modulatory element in the 5′-untranslated region of the myelin basic protein messenger RNA. J Biol Chem 265: 20314-20320.
31. Colson P, Ibarondo J, Devilliers G, Balestre MN, Duvoid A, et al. (1992) Upregulation of V1a vasopressin receptors by glucocorticoids. Am J Physiol 263: E1054-E1062.
32. Sarantos P, Chakrabarti R, Copeland EM, Souba WW (1994) Dexamethasone increases jejunal glutamine synthetase expression via translational regulation. Am J Surg 167: 8-13.
33. Ambuhl PM, Yang X, Peng Y, Preisig PA, Moe OW, et al. (1999) Glucocorticoids enhance acid activation of the Na+/H+ exchanger 3 (NHE3). J Clin Invest 103: 429-435.
34. Devarajan P, Benz EJ Jr. (2000) Translational regulation of Na-K-ATPase subunit mRNAs by glucocorticoids. Am J Physiol Renal Physiol 279: F1132-F1138.
35. Cougnon MH, Moseley AE, Radzyukevich TL, Lingrel JB, Heiny JA (2002) Na,K-ATPase alpha- and beta-isoform expression in developing skeletal muscles: alpha(2) correlates with 1-tubule formation. Pflugers Arch 445: 123-131.
36. Nordsborg N, Goodmann C, McKenna MJ, Bangsbo J (2005) Dexamethasone up-regulates skeletal muscle maximal Na+,K+ pump activity by muscle group specific mechanisms in humans. J Physiol 567: 583-589.
37. Gonzalez-Herrera IG, Prado-Lourenco L, Pilcur F, Conte C, Morin A, et al. (2006) Testosterone regulates FGF-2 expression during testis maturation by an IRES-dependent translational mechanism. FASEB J 20: 476-478.
38. Kim YK, Hahm B, Jang SK (2000) Polypyrimidine tract-binding protein inhibits translation of hip mRNA. J Mol Biol 304: 119-133.
39. Bushell M, Stoneley M, Kong YW, Hamilton TL, Spriggs KA, et al. (2006) Polypyrimidine tract binding protein regulates TRES-mediated gene expression during apoptosis. Mol Cell 23: 401-412.
40. Henis-Korenblit S, Shani G, Sines T, Marash L, Shohat G, et al. (2002) The caspase-cleaved DAT5 protein supports internal ribosome entry site-mediated translation of death proteins. Proc Natl Acad Sci U S A 99: 5400-5405.
41. Lewis SM, Cerquozzi S, Graber TE, Ungureanu NH, Andrews M, et al. (2008) The eIF4G homolog DAP5/p97 supports the translation of select mRNAs during endoplasmic recticulum stress. Nucleic Acids Res 36: 168-178.
42. Bonnal S, Pileur F, Orsini C, Parker F, Pujol F, et al. (2005) Heterogeneous nuclear ribonucleoprotein A1 is a novel internal ribosomc entry site trans-acting factor that modulates alternative initiation of translation of the fibroblast growth factor 2 mRNA. J Biol Chem 280: 4114-4153.
43. Lewis SM, Veyrier A, Hosszu UN, Bonnal S, Vaguer S, et al. (2007) Subcellular relocalization of a trans-acting factor regulates XIAP IRES-dependent translation. Mol Biol Cell 18: 1302-1311.
44. Fisher I, Abraham D, Bouri K, Hoffman EP, Munioni F, et al. (2005) Prednisolone-induced changes in dystrophic skeletal muscle. FASEB J 19: 831-836.
45. Lo C, V, Kanis JA, Beneton MN, Bertoldo F, Adami S, et al. (1995) Acute effects of deflazacort and prednisone on rates of mineralization and bone formation. Calcif Tissue Int 56: 109-112.
46. Rifai Z, Welle S, Moxley RT III, Lorenson M, Griggs RC (1995) Effect of prednisore on protein metabolism in Duchenne dystrophy. Am J Physiol 268: E67-E74.
47. Bonifati MD, Ruzza G, Bonometto P, Berardinelli A, Gorni K, et al. (2000) A multicenter, double-blind, randomized trial of deflazacort versus prednisone in Duchenne muscular dystrophy. Muscle Nerve 23: 1314-1347.
48. Campbell C, Jacob P (2003) Deflazacort for the treatment of Duchenne Dystrophy: a systematic review. BMC Neurol 3: 7.
49. Kissel JT, Burrow KL, Rammohan KW, Mendell JR (1991) Mononuclear cell analysis of muscle biopsies in prednisone-treated and untreated Duchenne muscular dystrophy. CIDD Study Group. Neurology 41: 667-672.
50. Wehling-Henricks M, Lee JJ, Tidball JG (2001) Prednisolone decreases cellular adhesion molecules required for inflammatory cell infiltration in dystrophin- deficient skeletal muscle. Neuromuscul Disord 11: 483-190.
51. Tinsley J, Deconinck N, Fisher R, Kahn D, Phelps S, et al. (1998) Expression or full-length utrophin prevents muscular dystrophy in mdx mice. Nat Med 4: 1441-1114.
52. Chakkalakal JV, Harrison MA, Carbonetto S, Chin E, Michel RN, et al. (2001) Stimulation of calcineurin signaling attenuates the dystrophic pathology in mdx mice. Hum Mol Genet 13: 379-388.
53. Krag TO, Bogdanovich S, Jensen CJ, Fischer MD, Hansen-Schwartz J, et al. (2004) Heregulin ameliorates the dystrophic phenotype in mdx mice. Proc Natl Acad Sci U S A 101: 13856-13860.
54. Ponta H, Kennedy N, Skroch P, Hynes NE, Groner B (1985) Hormonal response region in the mouse mammary tumor virus long terminal repeat can be dissociated from the proviral promoter and has enhancer properties. Proc Natl Acad Sci U S A 82: 1020-1024.
55. Gramolini AO, Dennis CL, Tinsley JM, Robertson GS, Cartaud J, et al. (1997) Local transcriptional control of utrophin expression at the neuromuscular synapse. J Biol Chem 272: 8117-8120.
56. Holcik M, Graber T, Lewis SM, Lefebvre CA, Lacasse E, et al. (2005) Spurious splicing within the XIAP 5′ UTR occurs in the Rluc/Fluc but not the betagal/CAT bicistronic reporier system. RNA 11: 1605-1609.
57. Blais JD, Addison CL, Edge R, Falls T, Zhao H, et al. (2006) Perk-dependent translational regulation promotes tumor cell adaptation and angiogenesis in response to hypoxic stress. Mol Cell Biol 26: 9517-9532.
58. Chakkalakal JV, Stocksley MA, Harrison MA, Angus LM, Deschenes-Furry J, et al. (2003) Expression of utrophin A mRNA correlates with the oxidative capacity of skeletal muscle fiber types and is regulated by calcineurin/NFAT signaling. Proc Natl Acad Sci U S A 100: 7791-7796.